Novartis: Depression trials
The registry lists 24 Depression studies with Novartis as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 14Phase 2 2Phase 3 7Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With IntentTerminatedNCT04722666Phase 2Results posted
- Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant DepressionCompletedNCT03756129Phase 2Results posted
- Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With DepressionTerminatedNCT01436643Phase 4Results posted
- Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)CompletedNCT01528241Phase 1
- Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)TerminatedNCT01156415Phase 3
- Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT01110902Phase 3
- Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive DisorderCompletedNCT01110889Phase 3
- To Demonstrate the Relative Bioavailability of Fluoxetine Hydrochloride Capsules, 40 mgCompletedNCT00947076Phase 1
- To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting ConditionsCompletedNCT00946764Phase 1
- To Demonstrate the Relative Bioequivalency of Comparing Single 100 mg Doses Of Cord's 50 mg Desipramine HCL Tablets To Merrell Dow's 50 mg Norpramin TabletsCompletedNCT00914004Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted ConditionsCompletedNCT00913952Phase 1
- To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride TabletsCompletedNCT00913822Phase 1
- To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin TabletsCompletedNCT00913809Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted ConditionsCompletedNCT00913783Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting ConditionsCompletedNCT00913718Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted ConditionsCompletedNCT00913588Phase 1
- To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl TabletsCompletedNCT00913419Phase 1
- To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg TabletsCompletedNCT00913237Phase 1
- A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting ConditionsCompletedNCT00864981Phase 1
- To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting ConditionsCompletedNCT00861939Phase 1
- Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00467402Phase 3
- A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)CompletedNCT00463242Phase 3
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411242Phase 3
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411099Phase 3